Načítá se...
Clinical features of chronic hepatitis B patients with YMDD mutation after lamivudine therapy
Objective: To study the clinical features of chronic hepatitis B (CHB) patients with tyrosine-methionine-aspartate-aspartate (YMDD) mutation after lamivudine therapy. Methods: This investigation was a retrospective study of 63 CHB patients with YMDD mutation during lamivudine therapy. Clinical data,...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Zhejiang University Press
2005
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1390641/ https://ncbi.nlm.nih.gov/pubmed/16358376 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1631/jzus.2005.B1182 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|